Accenture: Enters Agreement to Acquire Octagon Research Solutions

By Rob Starr, Content Manager, Big4.com

Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry, has been acquired by Accenture. David Boath, North American managing director for Accenture’s Life Sciences industry group comments:

“We believe that the timing is perfect for this acquisition as our clients are increasingly under pressure to reduce the drug development and approval timelines to get products to market more quickly, safely and cost effectively,” he said.  “Our clients have an urgent need to focus resources on the scientific breakthroughs and also to improve the efficiency of their clinical and regulatory operations. Octagon’s capabilities and experience will enable Accenture to provide comprehensive services spanning regulatory operations, submissions management, clinical data conversion and clinical data management.  The acquisition will enable Accenture to offer what we view as the industry’s first comprehensive regulatory services solution with a global footprint.”

The acquisition will enhance Accenture’s ability to help its pharmaceutical clients achieve more efficient global regulatory submissions that will enable them to get medicines to market more quickly, safely and at a lower cost. Octagon is headquartered in Wayne, Pa., and maintains additional U.S. and international operations in Mountain View, Calif.; London; and Bangalore, India.